29 Efficient generation of antibodies by B cells is one of the prerequisites of protective immunity. B 30 cell activation by cognate antigens via B cell receptors (BCR), or pathogen-associated molecules 31 through pattern-recognition receptors, such as Toll-like receptors (TLRs), leads to transcriptional and 32 metabolic changes that ultimately transform B cells into antibody producing plasma cells or memory 33 cells. BCR signaling and a number of steps downstream of it rely on coordinated action of cellular 34 membranes and the actin cytoskeleton, tightly controlled by concerted action of multiple regulatory 35 proteins, some of them exclusive to B cells. Here, we dissect the role of Missing-In-Metastasis (MIM), 36 or Metastasis suppressor 1 (MTSS1), a cancer-associated membrane and actin cytoskeleton regulating 37 protein, in B cell-mediated immunity by taking advantage of MIM knockout mouse strain. We show 38 undisturbed B cell development and largely normal composition of B cell compartments in the 39 periphery. Interestingly, we found that MIM -/-B cells are defected in BCR signaling in response to 40 surface-bound antigens but, on the other hand, show increased metabolic activity after stimulation with 41 LPS or CpG. In vivo, MIM knockout animals exhibit impaired IgM antibody responses to immunization 42 with T cell-independent antigen. This study provides the first comprehensive characterization of MIM in 43 B cells, demonstrates its regulatory role for B cell-mediated immunity, as well as proposes new 44 functions for MIM in tuning receptor signaling and cellular metabolism, processes which may also 45 contribute to the poorly understood functions of MIM in cancer. 46 47 2 Materials and Methods 101 2.
Introduction 48
Adaptive immune responses, such as efficient clearing of pathogens while maintaining the 49 homeostasis of the host, depend on fine-tuned balance of various signals. Increasing evidence points 50 towards an important role of the actin cytoskeleton and plasma membrane organization at the cross-51 roads of various signaling pathways orchestrating lymphocyte action (Mattila et al., 2016) . In B cells, 52 the actin cytoskeleton enables changes in cell morphology, required, for instance, during the formation 53 of the immunological synapse (Kuokkanen et al., 2015) . Interestingly, actin cytoskeleton and plasma 54 membrane also potently regulate B cell receptor (BCR) signaling (Treanor et al., 2010; Mattila et al., 55 2013 Mattila et al., 55 , 2016 . A plethora of cytoskeletal regulator proteins enable the multifaceted roles of the actin 56 cytoskeleton in living cells. Lymphocytes generally present very characteristic protein expression 57 patterns and considering the specialized functions of these immune cells, it is not surprising that this 58 also holds true for the regulators of the actin cytoskeleton. One best-known example of such protein is 59
Wiscott other hand, T cell-dependent immune responses appeared normal. Unlike BCR stimulation, MIM -/-B 96 cells were robustly activated by TLR agonists that, interestingly, also led to increased metabolic activity 97 in cells lacking MIM. Our study highlights the complex role of MIM in different cellular functions and 98 can serve as a stepping stone for unveiling the role of MIM -1 (preimmunization) and every week after immunization on days +7, +14, +21 and +28 for both 125 FICOLL and KLH cohorts. Secondary immunization of KLH cohort was performed on day +135 (0) and 126 blood was sampled on days +134 (-1), +139 (+4), +143 (+8) and +150 (+15). Coagulated blood was 127 spun at +4°C / 2000 rpm for 10 min and serum was collected and stored at -20°C. 128
All animal experiments were approved by the Ethical Committee for Animal Experimentation in 129
Finland. They were done in adherence with the rules and regulations of the Finnish Act Relative NP-specific antibody levels were extrapolated from reference curves prepared by serial dilution 155 of pooled serum, in which the highest dilution step received an arbitrary unit of 0.5. 156 157 2.5 Immunophenotyping 158
All cells were isolated in B cell isolation buffer (PBS, 2% FCS, 1 mM EDTA). Bone marrow cells 159
were isolated by flushing the buffer through mouse femoral and tibial bones. Splenocytes were isolated 160 by mashing the spleen in small buffer volumes with syringe plunger in 48-well plates. Peritoneal cavity 161 cells were isolated by filling the cavity with ~10 mL buffer volume through puncture and collecting the 162 fluid back. Cell suspensions were filtered through 70 µm nylon cell strainers. As a general flow 163 cytometry protocol all following steps were done in flow cytometry buffer I (PBS, 1% BSA). Fc-block 164 was done with 0.5 µL anti-mouse CD16/32 antibodies in 70 µL of flow cytometry buffer I for 10 min 165 and cells were stained for 30 min. Washings were done 3 times in 150 µL of flow cytometry buffer I. and with addition of 0.01% SDS for fluorescently-conjugated antibodies. Washing steps were done in 10 206 mL of TBST for 5 × 5 min. Membranes were scanned with Odyssey CLx (LI-COR) or visualized with 207
Immobilon Western Chemiluminescent HRP Substrate (WBKLS0500, Millipore) and ChemiDoc MP 208
Imaging System (Bio-Rad). Phospho-antibodies were stripped in 25 mM Glycine-HCl buffer, pH ~2.5 209 for 10 min, membranes were blocked and probed again for evaluation of total protein levels. Images 210
were background subtracted and the raw integrated densities for each band were measured in ImageJ. 211
Ratios of phosphorylated-vs-total protein levels were analyzed with ratio paired t test. For data 212 presentation these ratios were normalized to WT value at 0 min. 213 214 2.9 Intracellular Ca 2+ flux 215 Splenic B cells were resuspended at a concentration of 2.5-5 × 10 6 cell/mL in RPMI supplemented 216 with 20 mM HEPES and 2.5% FCS and loaded with 1 µM Fluo-4 (F14201, Thermo Fisher Scientific) 217 and 3 µM Fura Red (F3021, Thermo Fisher Scientific) for 45 min (+37°C, 5% CO 2 ). Cell suspension 218 was diluted in 10 volumes of complete RPMI and incubated for 10-15 min at RT. Cells were centrifuged 219 at 200 g, at RT for 5 min and resuspended at 2.5 × 10 6 cells/mL in PBS supplemented with 20 mM 220 HEPES, 5 mM glucose, 0.025% BSA, 1 mM CaCl 2 , 0.25 mM sulfinpyrazone (S9509, Sigma-Aldrich), 221
2.5% FCS. Cells were allowed to rest at RT for 20 min and were kept on ice before acquisition. Anti-222
IgM antibodies were added into prewarmed (+37°C, 5 min) B cell suspension aliquots to final 223 concentrations of 10, 5, 2.5 and 1 µg/mL and samples were acquired on BD LSR Fortessa. Alternatively, 224 equimolar concentrations of anti-IgM F(ab') 2 fragment were used. Fluorescence of Fluo-4 and Fura Red 225 were recorded by a continuous flow for 5 min. Data was analyzed in FlowJo and presented as 226 ratiometric measurement of Fluo-4/Fura Red median intensity levels. 227
Peritoneal cavity B cells were washed in L-15 medium, resuspended in 75 µL acquisition buffer 228 (HBS (HEPES buffered saline):L-15 (1:1 ratio), 2.5 µM probenecid (P8761, Sigma-Aldrich)) and 229 labeled by addition of 75 µL acquisition buffer with 10 µM Fluo-4 for 5 min at +37°C. Cells were 230
washed in 1 ml, resuspended in 200 µL and divided into two wells. B cells were prestained for 10 min 231 on ice with anti-CD23-AF594 antibodies, washed and resuspended in 100 µL of acquisition buffer on 232 ice. Samples were prewarmed (+37°C) in a total volume of 300 µL of acquisition buffer and 50 µL of 233 anti-IgM F(ab') 2 -AF633 were added. Cells were acquired on BD LSR Fortessa for 3-5 min and analyzed 234 in FlowJo. 235 236 2.10 Scanning electron microscopy 237
For the analysis of resting B cells, wells of the microscopy slides (10028210, Thermo Fisher 238
Scientific) were coated with CellTak (354240, Corning) in PBS (3.5 µg/cm 2 of surface area, according 239 to manufacturer's recommendations) for 20 min (RT), washed once with water and allowed to dry. For 240 the analysis of activated B cells, wells were coated with 5 µg/mL of anti-IgM in PBS for 1 h (RT) and 241 washed in PBS. 10 5 B cells in 20 µL of complete RPMI were placed on coated wells for 10 min (+37°C, 242 5% CO 2 ) and fixed by adding 20 µL PFA in PBS (4% PFA final, pH 7.0-7.5) for 15 min. Samples were 243 further fixed in 4% PFA/2.5% gluteraldehyde in PBS for 30 min, washed in PBS and post-fixed in 1% 244
OsO 4 containing 1.5% potassium ferrocyanide, and dehydrated with a series of increasing ethanol 245 concentrations (30%, 50%, 70%, 80%, 90%, 96% and twice 100%). Specimens were immersed in 246
hexamethyldisilazane and left to dry by solvent evaporation. The cells were coated with carbon using 247
Emscope TB 500 Temcarb carbon evaporator and imaged with Leo 1530 Gemini scanning electron 248 microscope. 249 250 2.11 Immunofluorescence microscopy and cell spreading 251 TIRF microscopy. MatTek microscopy dishes were coated with 7.5 µg/mL of anti-IgM antibodies in 252 PBS at +37°C for 30 min and washed once with PBS. Isolated splenic B cells (10 6 ) were left unstained 253 or labeled with 0.17 µL of anti-B220-AF647 antibodies in 400 µL PBS for 10 min in 1.5 mL tubes on 254 ice, spun (2500 rpm, 5 min), washed twice in 900 µL of ice-cold PBS and resuspended in 200 µL of 255
Imaging buffer (PBS, 10% FBS, 5.5 mM D-glucose, 0.5 mM CaCl 2 , 0.2 mM MgCl 2 ). Equal amounts of 256 unstained and labeled cells of different genotypes were mixed and loaded onto coated MatTek dishes at 257 35 µL/well. Cells were incubated for 10 min (+37°C, 5% CO 2 ), fixed in pre-warmed (+37°C) 4% 258 formaldehyde/PBS for 10 min (RT), permeabilized in 0.1% Triton X-100/PBS for 5 min (RT), washed 259 once with PBS and blocked in blocking buffer (PBS, 1% BSA) at +4°C (overnight). Cells were stained 260 with 1:50 Phalloidin-AF555 and 1:500 anti-pTyr primary antibody (4G10) in blocking buffer for 1 hr 261 (RT), washed 4 times with PBS, and stained with 1:500 secondary anti-mouse IgG2b-AF488 in blocking 262 buffer for 1 hr (RT), washed 4 times in PBS and imaged in PBS with total internal reflection 263 fluorescence (TIRF) mode in DeltaVision OMX Imaging System (GE Healthcare). TIRF images of 264 cortical actin and pTyr were processed with ImageJ macro using B220 and bright-field channels to 265 discriminate between attached WT or MIM-KO cells. Spreading area (determined on pTyr channel), 266 mean fluorescence intensity and total fluorescence intensity (integrated density) of phalloidin and pTyr 267 staining of each cell were analyzed (~50-340 cells per sample). For cumulative scatter plots, equal 268 numbers (here 92 cells) were randomly selected from each experiment. 269
Spinning disk confocal microscopy. 12-well PTFE diagnostic slides (Thermo Fisher Scientific, 270 #10028210) were coated with 5 µg/mL anti-mouse IgM (µ-chain-specific antibodies) in PBS at +4°C 271 O/N and washed with PBS. As a non-activated control, wells were coated with 4 µg/mL fibronectin. 272
Isolated splenic B cells (10 6 /ml) were labeled with 1µM CFSE (21888, Sigma-Aldrich) or left unlabeled. 273
Equal amounts of unstained and labeled cells of different genotypes were mixed (1:1 ratio) and seeded at 274 density of 100.000 cells/well. Dye-switched experiments were performed systematically. Cells were 275 incubated for 3, 5, 7, 10 or 15 min (+37°C, 5% CO 2 ), fixed in 4% formaldehyde/PBS for 10 min (RT) 276 and permeabilized/blocked in 0.3% Triton X-100/5% donkey serum/PBS for 20 min (RT Planar membranes were assembled on FCS2 dosed chambers (Bioptechs) and blocked with PBS/2% 293 FCS for 1 h at RT. Antigen was tethered by incubating membranes with AF647-streptavidin, followed 294 by monobiotinylated anti-kappa light chain antibodies (20 molecules/µm 2 ). The isolated B cells from 295
WT and MIM -/mice were labeled with 1µM CFSE (21888, Sigma-Aldrich) or left unlabeled, mixed at 296 1:1 ratio, and injected into prewarmed chambers (4 × 10 6 cells/chamber, +37°C) with 100 nM 297 recombinant murine CXCL13. Fluorescence, differential interference contrast (DIC), and interference 298 reflection microscopy (IRM) images were acquired at the plane of the cell contact in one position once 299 every 30 s immediately after injecting the cells into the chamber for 10 min. After the 10 min movie was 300 acquired, several snapshots were acquired for quantification of the mature synapses in different locations 301 of the chamber at 10-15 min after cell injection. All assays were performed in PBS, supplemented with 302 0.5% FCS, 0.5 g/L D-glucose, 2 mM MgCl and 0. staining in immunoblot, isolated from these mice showed no detectable MIM expression ( Fig. 1A ). To 366 investigate the possible functions of MIM in the B cell compartments, we first examined the B cells in 367 the bone marrow. We notified a slightly increased number of hematopoietic progenitors, as defined by 368 CD117 + CD19cells but found no apparent differences in the numbers of CD19 + and CD19 + IgM + 369 populations between age-matched wild type (WT) and MIM -/mice ( Fig. 1B-C, Suppl. Fig. S1B ). We 370 then carried out more detailed analysis of the bone marrow B cells with additional surface markers to 371 resolve consecutive developmental stages from common lymphoid progenitors to immature and mature 372 recirculating B cells (gating strategy shown in Suppl. Fig. S1A ). We found no significant differences 373 between WT and MIM -/mice in any of these developmental stages (Fig. 1D ). 374 375
Next, we went on to analyze the maturation of B cells and their different subsets in the periphery 376
(gating strategy shown in Suppl. Fig. S2A, B) . No defects were observed in the overall percentages of 377 CD19 + B cells or major T cell subsets in the spleen (Fig. 1E ). Also the proportions of transitional (T1-3) 378 and follicular (Fo) cells were not significantly altered, while marginal zone (MZ) B cells appeared 379 slightly elevated (Fig. 1F) . A special self-renewing population of B cells concentrate in the peritoneal 380
and pleural cavities. To analyze these B1 cells, we isolated cells from the peritoneal cavity of MIM -/and 381
WT mice. We found no significant differences in the proportions of CD5 + (B1a), CD5 -(B1b) or mature 382 peritoneal B cells (B2) (Fig. 1G) . intensities revealed similar elevation of intracellular Ca 2+ levels in both WT and MIM -/-B cells ( Fig. 2A,  399 Supplementary Fig S3F) . We also analyzed the calcium response in peritoneal cavity B cells, which 400
were loaded with Fluo-4, prestained with CD23-Alexa Fluor (AF)-594 just before acquisition and 401 stimulated with AF633-labeled anti-IgM antibodies, allowing distinction between B1 (IgM + CD23 -) and 402 B2 (IgM + CD23 + ) cells. Intracellular Ca 2+ mobilization was found comparable between WT and MIM -/-403 cells also in these two B cell subsets (Suppl. Fig. S3A ). 404 405
To study the BCR signaling in more detail, we next analyzed activation of individual components of 406 BCR signaling pathway by looking at phosphorylation levels of downstream effector molecules. Splenic 407 B cells were stimulated with soluble or surface-bound anti-IgM antibodies for 3, 7 and 15 min and 408 analyzed by immunoblotting. As expected, both stimulatory conditions induced rapid activation of BCR 409 signaling components, as detected by the levels of phosphorylated signaling proteins. Importantly, 410 MIM -/-B cells showed clear defects in signaling in response to surface-bound anti-IgM. Most of the 411 analyzed molecules, including Syk, CD19, Btk, p65 NF-κB and MAPK1/2 showed significant reduction 412 in their activation (Fig 2B, C) . Consistently, we found similar differences when using either 5 or 413 1 µg/ml of surface-tethered anti-IgM, or corresponding amounts of F(ab') 2 fractions of anti-IgM 414 (Suppl. Fig. S3D-E) . The signaling components studied can be classified into different cascades from the 415 proximal players to downstream effectors. While MIM -/cells showed robust defects in proximal 416 signaling molecules, the extent to which they affected the downstream cascades alternated. The defects 417 in PI3K pathway were largely recovered at the level of Akt. At the same time, the levels of pp65 NF-κB 418 and pMAPK1/2 were decreased, suggesting that MIM - The actin cytoskeleton is one of the major organizers of cell shape. To explore whether MIM -/-B 430 cells showed any changes in the overall morphology, we visualized them using scanning electron 431 microscopy (SEM), either in resting state or after 10 min activation by surface-tethered anti-IgM, 432
mimicking the formation of the immunological synapse. In SEM, the morphology of MIM -/-B cells 433 appeared grossly similar to WT cells (Fig. 3A) . However, to perform another, more quantitative 434 analysis, we turned to fluorescent microscopy. We activated B cells on anti-IgM-coated coverslips and 435
analyzed the area of spreading using total internal reflection fluorescence (TIRF) microscopy, an 436 imaging method ideal for visualization of the cell membrane-coverslip interface. The analysis of the 437 TIRF images revealed that MIM -/-B cells spread slightly but consistently less than their WT counterparts 438 (Fig. 3B ). To measure overall phosphorylation at the contact region, we stained the cells with anti-439 phospho-Tyrosine (pTyr) antibodies. Mean fluorescence intensities of pTyr were also reduced in MIM -/-440 B cells. To investigate the impaired BCR signaling and its kinetics in more details, we next activated the 441 B cells on anti-IgM coated coverslips for different timepoints and stained them with anti-pBtk and anti-442 pSyk antibodies, as well as phalloidin. Quantification of the pBtk and pSyk in the contact plane showed 443 significantly reduced levels of these signals, as well as levels of spreading, in MIM -/cells through 444 different time points ( Fig 3C) . The diminished area of spreading and kinase signaling detected by 445 microscopy are well in line with our results from immunoblotting that also showed impaired BCR 446 signaling. However, based on the SEM data and F-actin staining of the splenocytes, MIM -/cells do not 447 exhibit major morphological defects in their actin cytoskeleton ( Fig. 3A-C) . intensity profiles revealed no differences between MIM-KO and WT cells (Fig. 3D ). Next, we evaluated 459 the ability of MIM-KO cells to spread and form immunological synapses on SLBs. We performed live-460 cell imaging of WT and MIM-KO cells and recorded interference reflection microscopy (IRM) images 461 to detect the overall contact area of the cells, and fluorescent antigen signal to follow antigen gathering 462 in the synapse (Fig. 3E ). The movies showed fast cell spreading, reaching maximum in 1-2 minutes, 463 followed by slower contraction response coinciding with antigen accumulation to form the mature 464 immunological synapse. We did not detect any differences in the kinetics of synapse formation in MIM-465 KO cells as compared to WT counterparts. Also, in the mature synapses, analyzed after 10 minutes of 466 contact with the SLB, MIM -/-B cells accumulated normal amounts of antigen in the center of the 467 synapse ( Fig. 3E) . Thus, while MIM modulates BCR signaling and spreading responses upon antigen 468 contact on stiff substrates, upon engagement of membrane-bound mobile antigens the cells are able to 469 engage and gather normal amounts on antigen to the center of the immunological synapse. On 470 membranous surfaces, spreading and contraction response is complemented with dynamic fluctuations 471 of F-actin-rich protrusions, making the regulation of the cytoskeletal structures distinct from spreading 472 on immobilized antigens. 473 474
3
.4 MIM is required for an efficient antibody response against T-independent antigen 475
To test if the defected signaling in MIM -/-B cells leads into problems in mounting of the immune 476 responses, we went on to examine antibody levels of our mice first at the basal state and then upon 477 immunization with T cell-independent (TI) or T cell-dependent (TD) model antigens. We saw no 478 significant changes in the basal antibody levels in the sera of WT and MIM -/mice (Fig. 4A ). To study 479 the development of antibody responses towards TI antigens, we immunized mice with NP-FICOLL 480 ( Fig. 4B-D) . Throughout the examination time course of 28 days, we found reduced levels of both total 481
and NP-specific IgM in MIM -/mice (Fig. 4C) . Interestingly, we also detected impaired responses in the 482 total levels of IgG subtypes, most profound in IgG2b, while the production of NP-specific IgG 483 subclasses was not impaired (Fig. 4D) . 484 485
For immunizations with TD protein antigen, we used NP-KLH in alum and followed up the primary 486 response for four weeks. Four months later, we stimulated a memory response and followed that for 2 487 weeks (Suppl. Fig. S4A ). In contrast to TI immunization scheme, we found that MIM -/mice were as 488 efficient in mounting antibody responses to a protein antigen as their WT counterparts (Suppl. Fig. S4B-489 C). Analysis of the memory responses also showed equal levels of NP-specific IgG for all subclasses 490 (Suppl. Fig. S3D ). Furthermore, we analyzed affinity maturation by comparing binding to low and high 491 densities of NP-epitopes in ELISA, and found no significant differences between WT and MIM -/mice 492 (Suppl. Fig. S4E ). 493 494
In the light of defects in BCR signaling and TI immune responses in MIM -/mice, normal antigen-495 specific IgG immune responses may point towards compensation by other signals in the system, such as 496 T cell help. To dissect the B cell intrinsic features linked to IgG antibody responses in more detail, we 497 set up an in vitro assay for class-switch recombination (CSR). We provoked B cells to change the 498 isotype of the produced Ig molecules, by mimicking cellular events of pathogen encounter or T cell help 499 during maturation of IgG antibody responses. As expected, 3 days of B cells activation with LPS or 500 CD40L in combination with cytokines induced switching of surface-expressed Ig molecules to different 501
IgG isotypes, as detected by flow cytometry. Consistent with the in vivo data on generation of NP-502 specific IgG antibody responses, MIM -/-B cells switched normally in all tested conditions, producing 503 similar percentages of IgG + cells, indicating that MIM is not required for CSR in response to TLR 504 ligands or CD40L and cytokines. In fact, switching rates into the most common isotypes were even 505 slightly higher for MIM -/-B cells when stimulated with LPS (Suppl. Fig. S5A-D) . We also loaded the 506 cells with Cell Trace Violet dye, which allowed us to analyze fluorescence profiles of dividing splenic B 507 cells in response to these stimuli. We found robust proliferation of MIM -/-B cells when they were 508 activated with LPS, CD40L or anti-IgM + CD40L (Suppl. Fig. S5E ). Analysis of the proliferation 509 indices (PI) showed close to equal proliferation of MIM-KO and WT cells in all conditions tested. 510
Notably, the division indices (DI) of MIM -/-B cells were moderately, but significantly, increased in 511 CD40L + IFNg cultures, reflecting smaller numbers of cells left undivided, further indicating normal or 512 even improved ability of MIM -/cells to react to conditions similar to T cell help. 513 514
Our immunization studies suggest that MIM plays a role in IgM antibody responses to TI type 2 515 antigens, which haptenated FICOLL represents. However, MIM is dispensable for the development of 516 antibodies against TD protein antigens. The ability to switch the antibody class upon polyclonal 517 activation with LPS, TI type 1 antigen, appeared normal. Although by using a conventional MIM 518 knockout mouse model we cannot rule out the influence of other immune and stromal cells on the 519 immune responses generated in vivo, IgM antibody responses to TI antigens are considered to be largely 520 B cell intrinsic and in case of TI type 2 antigens rely primarily on intact BCR signaling. Thus, the 521 defects in IgM antibody responses are in line with the diminished BCR signaling observed in vitro 522 ( Fig. 2B-C; Fig 3B-C) . 523 524
.5 MIM -/-B cells show higher metabolic profile upon LPS and CpG stimulation 525
Our results suggest that MIM plays a role in antibody responses to TI-2 antigens. In vivo, however, 526
T Mito Stress test in the Seahorse platform. In this assay, serial injections of oligomycin, Carbonyl 536 cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) and rotenone/antimycin A (Rot/AA) mixture, 537 sequentially inhibit ATP production, collapse the proton gradient membrane potential and finally shut 538 down mitochondrial respiration. This system allows measurement of the basal OCR, maximal and spare 539 respiratory capacities, as well as determination of non-mitochondrial respiration. 540 541
First, we analyzed metabolic responses to individual stimulations with BCR ligands or TLR 542 agonists. To this end, we activated WT and MIM -/-B cells with LPS, CpG or anti-IgM + IL-4 for 24 h 543 or kept them largely resting with IL-4 alone (Fig. 5A ). Already samples treated with IL-4 alone showed 544 a slight but significant increase in the maximal respiration in MIM -/-B cells. Notably, we observed a 545 significant increase in the metabolic profile of MIM -/cells as compared to WT counterparts upon 546 activation with TLR4 and TLR9 ligands, LPS or CpG. Approximately 20% increase in the maximum 547 respiration of MIM -/cells was measured upon treatment with LPS or CpG. MIM -/cells also showed 548 similar increase in the basal OCR levels and almost two-fold upregulation for spare respiratory capacity 549 upon CpG activation. In contrast to TLR stimulations, 24 h activation via BCR led to a slight diminution 550 in basal respiration and no differences in maximum and spare respiration levels in MIM -/cells. The 551 preferred route of ATP generation, reflected by basal OCR to ECAR ratio, remained relatively constant 552 across conditions, indicating no major shifts in the balance of oxidative phosphorylation and glycolytic 553 metabolism. 554 555
To gain more understanding into the relationship of BCR and TLR signals in the activation of 556 MIM -/cells, we then asked how the metabolic reprogramming is affected by simultaneous engagement 557 of BCR and TLR. To this end, we cultured WT and MIM -/-B cells for 24 hrs with combination of anti-558
IgM + LPS or anti-IgM + CpG and analyzed their metabolic profiles (Fig. 5A) . Surprisingly, we found 559 that TLR-mediated increase in oxidative metabolism in MIM -/cells was restored to WT levels by 560 simultaneous BCR engagement. To more directly compare this data to anti-IgM-stimulated cells, where 561 IL-4 was added to increase survival of the cells, we carried out analysis of anti-IgM + LPS/CpG -562 stimulated cells also in the presence of IL-4. We found that simultaneous engagement of BCR also in 563 these conditions reverted the TLR-mediated increase in oxidative metabolism in MIM -/-B cells closer to 564 WT levels (Suppl. Fig. S6A ). However, the negative effect of anti-IgM was less efficient in presence of 565 IL-4, consistent with the finding that IL-4 supports metabolic reprograming towads higher oxidative 566 state levels in MIM -/cells . 567 568
Finally, we asked if the higher metabolic activity of MIM -/-B cells reflects a bona fide change in the 569 mitochondrial activity or is a result of elevated mitochondrial biogenesis upon TLR-mediated metabolic 570
reprograming. To this end, we stained mitochondria with TMRE and antibodies against Tom20 to assess 571 mitochondrial membrane potential and mitochondrial mass, respectively. In freshly isolated splenic 572 MIM -/-B cells, we found slightly but significantly elevated mitochondrial mass without significant 573 increase in mitochondrial membrane potential (Fig. 5B ). As expected, activation of B cells with either 574
anti-IgM + IL-4, LPS or CpG increased mitochondrial biogenesis and membrane potential, with CpG 575 inducing most potent response (Fig. 5C ). However, WT and MIM -/-B cells showed comparable levels of 576 mitochondrial membrane potential as well as mitochondrial mass after TLR stimulation. This suggests 577
that the changes we observed in the metabolic activity of MIM -/cells occur without detectable 578 additional mitochondrial biogenesis but are rather a function of increased efficiency that might not be 579 adequately represented by TMRE. Functional changes in the mitochondrial, and metabolic, activity may 580 also be reflected by cell size (Miettinen and Björklund, 2017). We found that CpG-but not LPS-or anti-581
IgM + IL-4-activated MIM -/cells often showed slightly increased forward scatter characteristics when 582 analyzed by flow cytometry (Suppl. Fig. S6B ). Together, our results suggest that in response to TLR4, 583 TLR9 or IL-4 stimulation, MIM negatively regulates metabolic reprograming of B cells, decreasing 584 reserves of oxidative metabolism, which are accompanied by functional changes in the mitochondrial 585 activity, rather than mitochondrial biogenesis. Interestingly, in MIM -/-B cells, simultaneous engagement 586 of BCR reverts TLR-mediated increase in oxidative mitochondrial activity. 587 588
4 Discussion 589
In this study, we examined the enigmatic cytoskeleton-membrane linker protein MIM in B cells, 590
where it is strongly expressed and also implicated in B cell lymphomas . In our mouse 591 model, we found diminished TI antibody responses, as well as defected BCR signaling, indicative of a 592 role in B cell activation and mounting of humoral immune responses. Together with the upregulated 593 metabolic boost and normal proliferative responses in MIM -/-B cells upon TLR activation, our data 594 suggest a complex role for MIM in modulation of different signaling pathways and cell fitness. 595
The predisposition of another MIM knockout mouse strain to lymphomagenesis, reported by Zhan 596 and colleagues, is intriguing . We found the spleens of MIM -/mice at the age of 2-7 597 months normal in size and cellularity, but as we did not perform aging experiments, we cannot preclude 598 problems later in life. Regarding B cell development, Zhan and colleagues at first showed aberrant levels 599 of total CD19 + or CD19 + IgM + cells in lymphoid organs ), yet later reported normal B 600 cell numbers (Zhan et al., 2016). Following the same gating strategy, the numbers of pre-B cells in our 601 MIM -/strain appeared normal (Suppl. Fig. S1B-C) , and we postulate that the observed discrepancies 602 may arise from differences in strain maintenance or mouse age at the time of immunophenotyping. The 603 possible consequences of the deletion of MIM for B cell development might also be too subtle to 604 manifest in all models. In our model, we however, noted mildly elevated numbers of MZ B cells in the 605 spleens of MIM -/mice (Fig. 1F) . The mouse strain generated by Zhan and colleagues used embryonic 606 stem (ES) cells with insertion of gene trap sequence between exons 3 and 4 (clone CSC156, 607
BayGenomics) (Yu et al., 2011) . Notably, an independent attempt to recapitulate the generation of proportions of peritoneal and even elevated MZ B cell compartments (Fig. 1F, G) , inadequate numbers 662 of these B cell populations are unlikely to be responsible for the reduced anti-NP IgM levels (Fig, 4C ). 663
However, further studies will be required to assess the functionality of B1 and MZ B cells in more 664 detail. We consider the defects in possible indirect T cell help unlikely, due to the low expression of 665 MIM in T cells , normal CD4 + T cell numbers (Fig. 1E ), intact antibody responses to 666 TD antigen NP-KLH (Suppl. Fig. S4 ) as well as comparable levels of class-switched IgG antibodies in 667 response to NP-FICOLL immunization (Suppl. Fig. S5 ). We suggest that the impaired NP-FICOLL 668 responses in MIM -/mice are caused by defected B cell receptor-mediated signaling, induced by cell 669 surface-associated FICOLL molecules. This would be in line with the prevailing idea that in vivo B cells 670 recognize and respond to antigens that are immobilized on the surface of other cells in the secondary 671 lymphoid organs (Carrasco and Batista, 2007) . In case of NP-KLH stimulation these defects could be 672 rescued by second signals, to which, based on our data, MIM -/cells respond well (Fig 5, Suppl. Fig. S5 Our results suggest that MIM plays a negative role in metabolic reprogramming of B cells towards 683 oxidative metabolic activity upon TLR4 and especially TLR9 engagement as we found that MIM -/-B 684 cells exhibited ~20% increased metabolic activity after stimulation with either LPS or CpG, respective 685
agonists for TLR4 and TLR9 (Fig. 5) . In contrast, basal OCR levels upon activation with anti-IgM + IL-686 4 were reduced in MIM -/cells reflecting impaired BCR signaling observed in these cells. It is possible 687 that STAT6-signaling triggered by IL-4 present in culture to increase the survival of the cells dilutes the 688 effects of defected anti-IgM signaling in MIM -/cells, and leads to underestimate of the difference, as 689 IL-4 alone lead to increased metabolic activity in MIM -/cells. 690 691
How exactly the impaired BCR signaling and abnormal metabolic rewiring of MIM -/-B cells in 692 response to TLR engagement can be explained together is an intriguing question. Surprisingly, addition 693 of BCR engagement at the same time with TLR agonists was found to negate the metabolic phenotype 694 found in MIM -/-B cells treated with TLR agonists alone. 
